Table 4.
Outcomes, positive versus clear margins, T1 and T2 stage.
| Total n = 963 | Positive margins n = 112 | Clear margins n = 851 | P value∗ | |
|---|---|---|---|---|
| Follow-up | ||||
| Years of follow-up median (range) | 7 (3–20) | 6 (3–19) | 7 (3–20) | 0.570 |
|
| ||||
| After initial management | ||||
| Disease free | 933 (97%) | 103 (92%) | 830 (98%) | 0.001 |
| Persistent disease | 30 (3%) | 9 (8%) | 21 (2%) | |
|
| ||||
| During follow-up | ||||
| Recurrence | 12 (1%) | 1 (1%) | 11 (1%) | 0.760 |
|
| ||||
| At last visit | ||||
| Persistent disease | 18 (2%) | 4 (4%) | 14 (2%) | 0.240 |
| Disease-free | 945 (98%) | 108 (96%) | 837 (98%) | |
Data are presented as number (percentages), unless otherwise specified. Recurrence percentage based on the number of disease free excluding the persistent disease. ∗Positive versus clear margins.